Draupnir Bio Overview

  • Founded
  • 2017
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $33.2M
Latest Deal Amount
  • Investors
  • 5

Draupnir Bio General Information


Developer of a medical research platform designed for exploring the glycome to develop novel therapeutics. The company's platform offers an array of technology, protein chemistry and advanced carbohydrate chemistry, enabling healthcare units with safe and effective glycomics-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • Solsikkevej 8
  • 8240 Risskov
  • Denmark
+45 51 00 00 00

Draupnir Bio Timeline

Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Draupnir Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Oct-2019 $33.2M 000.00 Completed Pre-Clinical Trials
2. Grant 30-Nov-2017 00000 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2017 Completed Pre-Clinical Trials
To view Draupnir Bio’s complete valuation and funding history, request access »

Draupnir Bio Executive Team (4)

Name Title Board Seat Contact Info
Simon Glerup Ph.D Co-Founder & Chief Executive Officer
Margrit Schwarz Chief Operating Officer
Camilla Gustafen Co-Founder & Chief Scientific Officer
Peder Madsen Co-Founder
To view Draupnir Bio’s complete executive team members history, request access »

Draupnir Bio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Draupnir Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
Novo Holdings Venture Capital Minority 000 0000 000000 0
Novo Nordisk Fonden Limited Partner 000 0000 000000 0
Accelerace Accelerator/Incubator Minority 000 0000 000000 0
Nordic Mentor Network Accelerator/Incubator 000 0000 000000 0
To view Draupnir Bio’s complete investors history, request access »